(ERF) Eurofins Scientific SE - Performance -1.5% in 12m
Compare ERF with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-22.02%
#48 in Group
Rel. Strength
41.07%
#4704 in Universe
Total Return 12m
-1.49%
#54 in Group
Total Return 5y
17.15%
#37 in Group
P/E 26.6
59th Percentile in Group
P/E Forward 13.6
50th Percentile in Group
PEG 0.56
79th Percentile in Group
FCF Yield 8.20%
84th Percentile in Group
12m Total Return: ERF (-1.5%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: ERF vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ERF
Total Return (including Dividends) | ERF | XBI | S&P 500 |
---|---|---|---|
1 Month | 13.99% | 2.28% | -0.87% |
3 Months | 8.19% | -10.48% | -7.58% |
12 Months | -1.49% | -1.83% | 11.88% |
5 Years | 17.15% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | ERF | XBI | S&P 500 |
1 Month | 78.1% | 56.6% | 23% |
3 Months | -7.40% | -89.3% | -88.5% |
12 Months | -33.9% | -42.4% | 55.1% |
5 Years | -65.9% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #60 | 11.5% | 15.0% |
3 Month | #30 | 20.9% | 17.1% |
12 Month | #54 | 0.34% | -12.0% |
5 Years | #37 | 34.2% | -44.3% |
FAQs
Does ERF Eurofins Scientific SE outperforms the market?
Yes,
over the last 12 months ERF made -1.49%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months ERF made 8.19%, while XBI made -10.48%.
Over the last 3 months ERF made 8.19%, while XBI made -10.48%.
Performance Comparison ERF vs Indeces and Sectors
ERF vs. Indices ERF is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.08% | 14.9% | 26.0% | -13.4% |
US NASDAQ 100 | QQQ | -3.11% | 12.6% | 25.6% | -14.2% |
US Dow Jones Industrial 30 | DIA | -1.14% | 17.2% | 26.1% | -10.7% |
German DAX 40 | DAX | -0.85% | 12.7% | 6.52% | -26.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.88% | 16.8% | 29.0% | -7.45% |
Hongkong Hang Seng | HSI | -1.09% | 13.9% | 24.1% | -15.4% |
India NIFTY 50 | INDA | 0.76% | 9.93% | 25.8% | -4.56% |
Brasil Bovespa | EWZ | -1.28% | 9.39% | 22.3% | 4.33% |
ERF vs. Sectors ERF is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.33% | 15.0% | 19.9% | -25.5% |
Consumer Discretionary | XLY | -2.16% | 14.1% | 23.5% | -14.8% |
Consumer Staples | XLP | 1.42% | 13.8% | 20.7% | -12.7% |
Energy | XLE | 2.40% | 27.9% | 31.8% | 9.60% |
Financial | XLF | -0.69% | 16.1% | 18.4% | -24.2% |
Health Care | XLV | -2.0% | 17.8% | 27.7% | -3.21% |
Industrial | XLI | -2.50% | 13.9% | 25.3% | -11.1% |
Materials | XLB | -1.47% | 16.4% | 33.5% | 2.03% |
Real Estate | XLRE | -0.56% | 15.3% | 26.9% | -19.6% |
Technology | XLK | -4.53% | 12.3% | 29.4% | -9.22% |
Utilities | XLU | 0.76% | 13.9% | 23.9% | -23.3% |
Aerospace & Defense | XAR | -3.03% | 7.60% | 12.5% | -28.1% |
Biotech | XBI | -3.38% | 11.7% | 38.7% | 0.34% |
Homebuilder | XHB | -1.39% | 16.3% | 40.9% | 5.54% |
Retail | XRT | -0.51% | 14.6% | 31.6% | 1.25% |